OxyContin maker Purdue Pharma LP’s plan to turn over its operations to creditors and see its owners, the Sacklers, exit the opioid business is contingent on first resolving U.S. Justice Department probes, court filings show.
The disclosure emerged late Tuesday in a proposed term sheet Purdue filed in U.S. Bankruptcy Court in New York that publicly lays out for the first time details of the company’s plan to resolve its sprawling opioid liabilities.
The Sackler family members directly involved in Purdue should be in jail for a long time. The rules are different for the ultra-wealthy vs the rest of us.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: